Sotabase

Career

· CTO, J2 Global, Inc. (now Ziff Davis, Inc.)2018–
· CTO, Ziff Davis, Inc.2011–
· Senior Vice President of Engineering, VINDICO Group2010–2011
· Vice President of Engineering, Quigo Technologies, Inc.2007–2008
· Master's Degree in Computer Science, Columbia University
· Bachelor's degree, Georgetown University
· Co-founder and Vice President of Technology, Pseudo Programs, Inc.

Publications (35)

Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Experimental Hematology · 1993
67
cited
Cycling Status of CD 34 " Cells Mobilized Into Peripheral Blood of Healthy Donors by Recombinant Human Granulocyte Colony-Stimulating Factor
1997
25
cited
Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studies.
Experimental Hematology · 1997
25
cited
Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Experimental Hematology · 1994
25
cited
Positive selection of hematopoietic CD34+ stem cells provides 'indirect purging' of CD34- lymphoid cells and the purging efficiency is increased by anti-CD2 and anti-CD30 immunotoxins.
Bone Marrow Transplantation · 1994
24
cited
Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Haematologica · 1998
20
cited
20
cited
Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Experimental Hematology · 1995
18
cited
Sotabase
Joey Fortuna | Researcher Profile | Sotabase | Sotabase